Log In
Print
BCIQ
Print
Print this Print this
 

Biosimilar rituximab (MK-8808)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionRituximab biosimilar
Molecular Target CD20
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today